Search for: "Novartis Pharmaceuticals Corporation"
Results 201 - 219
of 219
Sort by Relevance
|
Sort by Date
11 Feb 2008, 9:20 am
February 2008 Australian Report Links Liver Failure And Hepatitis To Popular Novartis Drug (Posted by Tom Lamb at DrugInjuryWatch.com) A February 4, 2008 article, "Anti-fungal tablet linked to liver deaths", published by Australia's Herald Sun newspaper, brought to our attention the fact that Australian drug regulators have issued a warning about serious liver reactions after taking a popular prescription drug used to treat fungal infections, Lamisil (terbinafine),… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy':… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
27 Dec 2007, 7:09 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
14 Dec 2007, 1:00 am
: (Patent Prospector) PharmaAggregate launches new online presence: (MaRS Blog - Innovation and Commercialization in Canada)Japan Plans Generic Drug Incentives to Cut Down Medical Costs: (MedIndia), Interesting commentary and article on generic/ innovator company patent settlements: (Generic Pharmaceuticals & IP), Global trends in commencement of patent actions by innovators: (Generic Pharmaceuticals & IP), Is… [read post]
25 Nov 2007, 11:04 am
And the New Jersey defendants did not appear to be sham: They were Novartis Pharmaceuticals Corporation and Novartis Corporation, which presumably played a significant role in manufacturing or selling the drug that allegedy killed the plaintiffs' child.And the plaintiffs seemingly made good faith efforts to serve the complaint on Novartis Pharmaceuticals Corporation. [read post]
26 Oct 2007, 2:03 am
Court of Appeal (Civil Division) Neil Martin Ltd v HM Revenue & Customs [2007] EWCA Civ 1041 (25 October 2007) Cadogan & Anor v Sportelli & Anor [2007] EWCA Civ 1042 (25 October 2007) Boudh v Bodh [2007] EWCA Civ 1019 (25 October 2007) AA (Somalia) v SSHD [2007] EWCA Civ 1040 (25 October 2007) Kohn v Wagschal & Ors [2007] EWCA Civ 1022 (24 October 2007) Poole & Ors v HM Treasury [2007] EWCA Civ 1021 (24 October 2007) Wright & Ors, R (on the… [read post]
21 Oct 2007, 12:55 pm
On March 30, 2007, the FDA requested that Novartis Pharmaceuticals Corporation ("Novartis"), the manufacturer of Zelnorm, voluntarily remove the drug from the market. [read post]
12 Oct 2007, 7:03 am
Novartis Pharmaceuticals Corp., 2007 WL 2330713, at *4 (S.D. [read post]
19 Aug 2007, 5:13 pm
Novartis Pharmaceuticals Corporation et al. v. [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]
27 Apr 2007, 12:04 pm
Yesterday, eighty minutes before the hearing the attendants' line stretched down the corridor with numerous ill-dressed folks lounging on the floor or in chairs ("seat holders" selling their places in line to corporate VP's and lobbyists); those coming later had to sit in an overflow video-feed room; ten or so members of the subcommittee participated in the hearings, some showing significant insight. [read post]
10 Apr 2007, 1:49 pm
"The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems)... [read post]
3 Apr 2007, 2:55 pm
Novartis Suspends Sales After FDA Determines That Risks Of Serious Side Effects Outweigh Benefits Of Zelnorm (Posted by Tom Lamb at DrugInjuryWatch.com) On March 30, 2007 the FDA announced that Novartis Pharmaceuticals Corporation had suspended the marketing and sales of Zelnorm (tegaserod), a widely prescribed medication for irritable bowel syndrome (IBS) and constipation, due to an apparent increased risk of heart attacks and strokes in patients using Zelnorm.… [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter… [read post]
2 Mar 2007, 9:06 am
At the March 6 annual meeting of Swiss pharmaceutical giant Novartis, chairman and CEO Daniel Vasella and Hans-Joerg Rudloff, chair of the compensation committee, are up for reelection. [read post]
21 Nov 2006, 12:04 pm
Novartis Pharmaceuticals Corporation, No. 05-CV-5350, and was filed in the U.S. [read post]
22 Sep 2006, 12:17 pm
While the FDA has approved Novartis AG's Omnitrope hormone, there has not been a change in the stance taken by the FDA on generic biotechnology drugs. [read post]
